account_id none on file
legal_name BriaCell Therapeutics Corp.
ticker BCTX
cik 1610820
domain briacell.com
linkedin_company_url https://www.linkedin.com/company/briacell-therapeutics-corp/
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 4 executives 0 family 0
why_nownone on file
callsnone on file
filings
and travel expenses. Financial income, net For the three-month period ended April 30, 2026, the Company recorded net financial income of $186,970, compared to net financial expense of $9,762 in the same period of 2025.
filing / Jun 9, 2026 / receipt
were partially offset by lower professional fees, which decreased from $875,632 in 2025 to $667,463 in 2026, and lower travel expenses,
filing / Jun 9, 2026 / receipt
and salaries increased from $3,544,267 in 2025 to $4,677,662 in 2026, due to increased headcount and personnel supporting clinical and
filing / Jun 9, 2026 / receipt
and travel expenses, partially offset by higher wages and salaries, regulatory, filing and transfer agent fees, insurance, and other
filing / Mar 10, 2026 / receipt
executivesnone on file
familynone on file
upcoming
| 2026-10-21 | earnings call | scheduled | ir |
changesnone on file
mcp_package_hint
slug briacell-therapeutics-corp
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$